Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
175k share core????? Good Lord! I'm at 19k :) A lot for me though.
Hopefully holding for dollars
GL!
Shares Outstanding 65,642,095 a/o Feb 13, 2014
Monster in the making IMO. Hold, Add, Hold
Its been a long road but I believe one day IBIO will be a huge money maker. A monster is in the making IMO. Plus Dart hasnt' sold a share and bought more this last year.
I know its a lot of my money tied up, but I believe in the end game.
As always, thanks for your support CJ
IBIO!!!
Ugggly day, everything I own is in the crapper
2.7 mil volume eh?
Its a matter of time for MMRF and CVS to get together IMO
$IBIO Chart : https://www.tradingview.com/v/4FO1BBfv/
The Company plans to make additional announcements over the next several days.
Hey! We are supposedly partnered with Legal Zoom! Or at least we were back in the day
The Company plans to make additional announcements over the next several days.
Patents and Patents and Patents and Patents
MMR Expands Patent Portfolio to Legal Records
"MMR received a Notice of Allowance from the U.S. Patent Office dated March 24, 2014 on U.S. Patent Application Serial No. 12/204,498 titled "METHOD AND SYSTEM FOR PROVIDING ONLINE RECORDS." The allowed application expands MMR's Health Information Technology Patent Portfolio to includes claims directed towards accessing and collecting legal records amongst other things. The Company plans to make additional announcements over the next several days.
$IBIO Time kids, whoooo's coming with me
http://stockcharts.com/h-sc/ui?s=IBIO&p=D&yr=0&mn=3&dy=0&id=p52408368898
Nice
Welcome back to iBio buddy :)
$NCTY letter of intent for 32 mil
Swipe away, but realize that alcohol is much, much worse for the population than smoking weed. People die daily from alcohol abuse and drunk driving, people sleep on couches daily from smoking too much weed :)
Anywho, we agree to disagree and that's A OK with me!
Now back to ripping on Lorsch, where's the money! LOL
You are obviously entitled to your opinion but dont swipe a market at an entire topic, weed does plenty of really great things for people who need it
Giddy up again :)
Giddy up
CELG?
Exsqueeze me EZ, are you insinuating that iBio isn't a real company!
Gasp!
You should go tell that to Bill and Melinda Gates!
http://ibioinc.com/products/
Isn't that like an oxyMORON
Was the filing for the previous placements we heard about or is this additional financing?
(Sorry hard to read on my phone)
Thanks again Funman!
Great, thanks
Hey FunMan, can you expand on your reasons of the stock perhaps going to $10 if/when insurance reimbursements are in play.
Not to be lazy but what would the market cap be at $10, I'm not actually sure what our O/S is
I can look this up later but thought I'd ask if you knew off the top of your head.
Also have you ever been part of other companies that went through the same thing?
TIA
The chart was perfect and now the Bird Flu news from China is in play.
http://yourhealth.asiaone.com/content/chinas-h7n9-bird-flu-outbreak-epidemic-who
Whats with this one? Chart looks really, really bad, hope you don't own!
The chart is a thing of beauty
http://stockcharts.com/h-sc/ui?s=IBIO&p=D&yr=0&mn=3&dy=0&id=p18050983303
$IBIO up on good volume
Bob trying to slang MMR to Qatar per FB post
http://www.onlineqatar.com/
Top Medical Technology Innovation to Watch Out For
1. Cutting Back on Melanoma Biopsies
With the most deadly form of skin cancer, melanoma, a huge number of dangerous-looking moles are actually harmless, but has always been impossible to know for sure without an invasive surgical biopsy. Today dermatologists have new help in making the right call — a handheld tool approved by the FDA for multispectral analysis of tissue morphology. The MelaFind optical scanner is not for definitive diagnosis but rather to provide additional information a doctor can use in determining whether or not to order a biopsy. The goal is to reduce the number of patients left with unnecessary biopsy scars, with the added benefit of eliminating the cost of unnecessary procedures. The MelaFind technology (MELA Sciences, Irvington, NY) uses missile navigation technologies originally paid for the Department of Defense to optically scan the surface of a suspicious lesion at 10 electromagnetic wavelengths. The collected signals are processed using heavy-duty algorithms and matched against a registry of 10,000 digital images of melanoma and skin disease.
http://www.techcityng.com/medical-technology-innovation/
Julie E. Russak, M.D., FAAD, Leading Dermatologist Announces Opening of New Clinic in Midtown Manhattan
State-of-the-Art Practice Specializes in Medical, Cosmetic, and Pediatric Dermatology
Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Dr. Julie Russak
With the opening of our new clinic, people who work or live in Manhattan and beyond will now have access to the highest level of care and most current medical and cosmetic technology for lifelong healthy skin, all in one convenient location
New York, NY (PRWEB) March 13, 2014
Julie E. Russak, M.D., FAAD, announces the opening of Russak Dermatology Clinic, a state-of-the-art practice that provides comprehensive care in medical dermatology, dermatological surgery, and non-surgical cosmetic dermatology in midtown Manhattan. Dr. Russak, a melanoma expert, treats an extensive range of medical conditions for adult and pediatric patients while also offering the latest cosmetic treatments that require little or no downtime, including injectables, laser treatments, and an array of non-invasive rejuvenation procedures.
“With the opening of our new clinic, people who work or live in Manhattan and beyond will now have access to the highest level of care and most current medical and cosmetic technology for lifelong healthy skin, all in one convenient location,” says Dr. Russak, a board-certified dermatologist who is also an assistant clinical professor at the Mount Sinai Hospital in New York City. “Our goal is to provide the advanced skills and services, personalized attention, and positive patient experience that are key to the most effective dermatological care.”
Russak Dermatology Clinic is located in the GALLERIA building at 115 East 57th Street. Designed by the internationally acclaimed Antonio Tadrissi of Prototype Design Lab, known for its innovative architecture style, the stylish boutique space features amazing views of midtown Manhattan and sleek and spacious treatment rooms equipped with the latest technology and amenities. Flat screens in every room and wi-fi accessibility throughout the clinic ensure a comfortable and relaxing patient experience.
The clinic offers treatments for a wide variety of medical conditions of the skin, hair, and nails, including skin cancer, acne, rosacea, psoriasis, hair loss, and varicose veins. Within the medical division, Dr. Russak is one of the few doctors in New York City to be trained in the use of MelaFind®, the first FDA-approved non-invasive and painless medical device to detect melanoma in its earliest stages. She also provides dermatological skin-cancer surgery
on the premises.
The aesthetic division features such cosmetic services as laser treatments; intense pulsed light facial rejuvenation; fractional resurfacing to address skin texture and tone, scars, and stretch marks; and injections of dermal fillers and neuromodulators (Botox®, Dysport™, and Xeomin®). Russak Dermatology Clinic is one of the first practices in Manhattan to offer Juvéderm Voluma™ XC, the filler for the mid face to correct age-related volume loss that was FDA-approved in November 2013 for use in the cheek area. It is also one of the few dermatology practices in New York to offer Dermaplaning, a quick, safe, and effective method of exfoliating the skin and ridding it of vellus hair (peach fuzz). Other popular procedures include Belotero Balance®, a dermal filler specially designed to integrate into the skin and mold to a patient’s distinct facial contours; hand rejuvenation, a combination of fractional laser resurfacing, dermal fillers, and Ultherapy®; and liquid facelift, a mix of dermal fillers and neuromodulators.
Dr. Russak also provides a comprehensive skincare analysis and personalized skincare regimen for all her patients. Basing her advice on clinical studies, the latest understanding of skin molecular structure, and ingredient formulations that have been proven effective, Dr. Russak creates a customized cocktail of topical antioxidants, growth factors, and peptides to address an array of skincare concerns.
For more information about Julie E. Russak, M.D., and Russak Dermatology Clinic, visit russakdermatology.com or follow her practice on Facebook and Twitter (@RussakDerm). To interview or make an appointment with Dr. Russak, contact Juliet Cavallaro at juliet(at)russakdermatolgy.com or (646) 873-7546.
About Julie E. Russak, M.D.
Dr. Russak is a board-certified dermatologist, a Fellow of the American Academy of Dermatology, and a member of the American Society of Dermatologic Surgery. She graduated with honors from New York University School of Medicine and completed her dermatology residency at the Dartmouth Hitchcock Medical Center, where she served as chief resident. She completed an Oncology Melanoma Fellowship with world-renowned melanoma expert Darrell Rigel, M.D., and is the recipient of the Marianne Salzberg Award in Dermatology and the Jonas E. Salk Scholar Award. In addition to having a thriving practice, she is an assistant clinical professor at Mount Sinai Hospital, where she teaches dermatology residents and medical students.
http://www.prweb.com/releases/2014/03/prweb11665443.htm
Great post, and as always, I hope you are right :)